From Casetext: Smarter Legal Research

Herriott v. Sanofi-Aventis U.S. LLC

UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT
Aug 27, 2019
No. 17-56913 (9th Cir. Aug. 27, 2019)

Opinion

No. 17-56913

08-27-2019

PARKER R. HERRIOTT, Plaintiff-Appellant, v. SANOFI-AVENTIS U.S. LLC; et al., Defendants-Appellees.


NOT FOR PUBLICATION

D.C. No. 2:16-cv-09181-JAK-GJS MEMORANDUM Appeal from the United States District Court for the Central District of California
John A. Kronstadt, District Judge, Presiding Before: SCHROEDER, PAEZ, and HURWITZ, Circuit Judges.

This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.

Parker R. Herriott appeals pro se from the district court's order dismissing his product liability and medical malpractice action and denying his motion to remand to state court. We have jurisdiction under 28 U.S.C. § 1291. We review de novo subject matter jurisdiction and denials of motions to remand. Ritchey v. Upjohn Drug Co., 139 F.3d 1313, 1315 (9th Cir. 1998). We affirm.

The district court properly concluded that Dr. Kneisley was fraudulently joined because the claims against Dr. Kneisley were barred by the statute of limitations. See Cal. Civ. Proc. Code § 340.5 (statute of limitations for a California medical malpractice claim is "three years after the date of injury or one year after the plaintiff discovers ... the injury, whichever occurs first."); Drexler v. Petersen, 209 Cal. Rptr.3d 332, 340 (Ct. App. 2016) (when a patient experiences appreciable harm, that appreciable harm will start the limitations period); Grancare, LLC v. Thrower by & through Mills, 889 F.3d 543, 548 (9th Cir. 2018) ("We have upheld rulings of fraudulent joinder where a defendant demonstrates that a plaintiff is barred by the statute of limitations from bringing claims against that defendant."). Because Dr. Kneisley was fraudulently joined, the district court properly dismissed the claims against him, and because the remaining parties were diverse, the district court properly denied Herriott's motion to remand. See 28 U.S.C. § 1332.

We do not consider matters not specifically and distinctly raised and argued in the opening brief, or arguments raised for the first time on appeal. See Padgett v. Wright, 587 F.3d 983, 985 n.2 (9th Cir. 2009).

The request of Defendant Sanofi-Aventis to be removed from the electronic service list (Docket Entry No. 12) is granted.

AFFIRMED.


Summaries of

Herriott v. Sanofi-Aventis U.S. LLC

UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT
Aug 27, 2019
No. 17-56913 (9th Cir. Aug. 27, 2019)
Case details for

Herriott v. Sanofi-Aventis U.S. LLC

Case Details

Full title:PARKER R. HERRIOTT, Plaintiff-Appellant, v. SANOFI-AVENTIS U.S. LLC; et…

Court:UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT

Date published: Aug 27, 2019

Citations

No. 17-56913 (9th Cir. Aug. 27, 2019)